Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Seres Therapeutics completes IPO

    Seres Therapeutics Inc. (NASDAQ:MCRB), Cambridge, Mass. Business: Infectious, Endocrine/Metabolic, Inflammation Date completed: 2015-06-26 Type: IPO Raised: $133.7 million Shares: 7.4 million Price: $18 Shares after …

    Published on 6/29/2015
  • Sqz Biotechnologies completes venture financing

    Sqz Biotechnologies Co., Boston, Mass. Business: Gene/Cell therapy, Supply/Service Date completed: 2015-06-24 Type: Venture financing Raised: $5 million Investors: Polaris Partners; 20/20 Healthcare Partners ; and other…

    Published on 6/29/2015
  • TapImmune completes warrant exercise

    TapImmune Inc. (OTCQB:TPIV), Seattle, Wash. Business: Cancer, Infectious Date completed: 2015-06-18 Type: Warrant exercise Raised: $2.5 million Shares: 5 million Price: $0.50 Shares after offering: 37.6 million Investor…

    Published on 6/29/2015
  • ViraTherapeutics completes venture financing

    ViraTherapeutics GmbH, Innsbruck, Austria Business: Cancer Date completed: 2015-06-24 Type: Venture financing Raised: EUR3.6 million ($4.1 million) Investors: Boehringer Ingelheim Venture Fund; EMBL Ventures; Austria …

    Published on 6/29/2015
  • Western Oncolytics completes venture financing

    Western Oncolytics Ltd., Westlake, Ohio Business: Cancer Date completed: 2015-06-22 Type: Venture financing Raised: $2.5 million Investor: Tiberius II

    Published on 6/29/2015
  • Biodesix financial update

    Biodesix Inc., Boulder, Colo. Business: Diagnostic Date announced: 2015-06-23 Note: Biodesix raised an additional $11 million in a series E, bringing the total raised in the round to $38 million. Existing investors …

    Published on 6/29/2015
  • BiondVax financial update

    BiondVax Pharmaceuticals Ltd. (Tel Aviv:BVXV; NASDAQ:BVXV), Ness Ziona, Israel Business: Infectious Date announced: 2015-06-24 Note: BiondVax raised $550,000 through the sale of 110,000 ADSs at $5 to cover the …

    Published on 6/29/2015
  • Nevro financial update

    Nevro Corp. (NYSE:NVRO), Menlo Park, Calif. Business: Neurology Date announced: 2015-06-23 Note: Nevro raised $36 million through the sale of 705,882 shares at $51 to cover the overallotment from its June 3 follow-on, …

    Published on 6/29/2015
  • Nivalis Therapeutics financial update

    Nivalis Therapeutics Inc. (NASDAQ:NVLS), Boulder, Colo. Business: Pulmonary, Inflammation, Autoimmune Date announced: 2015-06-23 Note: Nivalis raised $11.6 million through the sale of 825,000 shares at $14 to cover the …

    Published on 6/29/2015
  • Sanford Burnham Prebys Medical Discovery Institute financial update

    Sanford Burnham Prebys Medical Discovery Institute, La Jolla, Calif. Business: Other Date announced: 2015-06-24 Note: Sanford Burnham Prebys Medical Discovery Institute (formerly Sanford-Burnham Medical Research …

    Published on 6/29/2015
  • Benitec proposes follow-on

    Benitec Biopharma Ltd. (ASX:BLT), Sydney, Australia Business: Functional genomics, Proteomics Date announced: 2015-06-22 Type: Follow-on To be raised: Up to $70 million Shares: TBD Price prior: A$0.78 Underwriters: BMO …

    Published on 6/29/2015
  • Conkwest proposes IPO

    Conkwest Inc., Cardiff-by-the-Sea, Calif. Business: Cancer Date announced: 2015-06-22 Type: IPO To be raised: Up to $172.5 million Shares: TBD Price: TBD Underwriters: BofA Merrill Lynch; Citigroup; Jefferies; Piper …

    Published on 6/29/2015
  • International Stem Cell proposes private placement of common stock and warrants

    International Stem Cell Corp. (OTCQB:ISCO), Carlsbad, Calif. Business: Gene/Cell therapy, Transplant Date announced: 2015-06-24 Type: Private placement of common stock and warrants To be raised: Up to $6 million Shares:…

    Published on 6/29/2015
  • Motif Bio proposes placing

    Motif Bio plc (LSE:MTFB), London, U.K. Business: Infectious Date announced: 2015-06-23 Type: Placing To be raised: Up to L22 million ($34.9 million) Shares: 44 million Price: 50p Shares outstanding prior: 64.2 million …

    Published on 6/29/2015
  • Neos Therapeutics proposes IPO

    Neos Therapeutics Inc., Grand Prairie, Texas Business: Drug delivery, Neurology Date announced: 2015-06-19 Type: IPO To be raised: Up to $69 million Shares: TBD Price: TBD Underwriters: UBS; BMO Capital Markets; RBC …

    Published on 6/29/2015
  • BioPharmX amends follow-on

    BioPharmX Corp. (OTCQB:BPMX), Menlo Park, Calif. Business: Drug delivery, Genitourinary, Dermatology Date announced: 2015-06-16 Type: Follow-on To be raised: Up to $10.8 million Shares: 3.3 million Price prior: $3 …

    Published on 6/22/2015
  • DelMar Pharma amends follow-on

    DelMar Pharmaceuticals Inc. (OTCQX:DMPI), Vancouver, B.C. Business: Cancer Date announced: 2015-06-12 Type: Follow-on To be raised: Up to $8 million Shares: 11.9 million Price prior: $0.71 Underwriters: Maxim Group; …

    Published on 6/22/2015
  • Kiadis Pharma amends IPO

    Kiadis Pharma B.V., Amsterdam, the Netherlands Business: Cancer, Transplant, Gene/Cell therapy Date announced: 2015-06-17 Type: IPO To be raised: Up to EUR31.2 million ($35.1 million) Shares: 2.3 million Price: EUR11-…

    Published on 6/22/2015
  • Lantheus Holdings amends IPO

    Lantheus Holdings Inc., North Billerica, Mass. Business: Diagnostic Date announced: 2015-06-16 Type: IPO To be raised: Up to $82.9 million Shares: 7.9 million Price: $8.50-$10.50 Underwriters: Credit Suisse; Jefferies; …

    Published on 6/22/2015
  • Pieris Pharmaceuticals amends follow-on

    Pieris Pharmaceuticals Inc. (OTCQB:PIRS), Freising-Weihenstephan, Germany Business: Autoimmune, Inflammation, Cancer Date announced: 2015-06-17 Type: Follow-on To be raised: Up to $34.5 million Shares: 9.6 million Price…

    Published on 6/22/2015
  • Seres Therapeutics amends IPO

    Seres Therapeutics Inc., Cambridge, Mass. Business: Infectious, Endocrine/Metabolic, Inflammation Date announced: 2015-06-16 Type: IPO To be raised: Up to $106.3 million Shares: 6.3 million Price: $15-$17 Underwriters: …

    Published on 6/22/2015
  • Adrenergics completes venture financing

    Adrenergics Inc., San Diego, Calif. Business: Cardiovascular Date completed: 2015-06-15 Type: Venture financing Raised: $3 million Investors: Avalon Ventures; GlaxoSmithKline plc

    Published on 6/22/2015
  • Advanced Cell Diagnostics completes venture financing

    Advanced Cell Diagnostics Inc., Hayward, Calif. Business: Diagnostic Date completed: 2015-06-18 Type: Venture financing Raised: $22 million Investors: Summit Partners; Kenson Ventures; Morningside Venture Investments; …

    Published on 6/22/2015
  • Affiris completes venture financing

    Affiris AG, Vienna, Austria Business: Neurology, Cardiovascular, Endocrine/Metabolic Date completed: 2015-06-16 Type: Venture financing Raised: EUR10 million ($11.2 million) Investors: Santo Holding; MIG Funds

    Published on 6/22/2015
  • Batu Biologics completes venture financing

    Batu Biologics Inc., San Diego, Calif. Business: Cancer Date completed: 2015-06-18 Type: Venture financing Raised: $1 million Investors: Private investors; angel investors

    Published on 6/22/2015

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993